Correction to Lancet Oncol 2018; 19: 1516-29
- PMID: 30507433
- DOI: 10.1016/S1470-2045(18)30820-9
Correction to Lancet Oncol 2018; 19: 1516-29
Erratum for
-
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.Lancet Oncol. 2018 Nov;19(11):1516-1529. doi: 10.1016/S1470-2045(18)30515-1. Epub 2018 Oct 15. Lancet Oncol. 2018. PMID: 30337220 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
